article thumbnail

Drug Allergy

RX Note

A person who takes a certain drug may experience rashes, while another person who takes the same drug may not have any adverse reactions. Collectively, drug allergy, intolerance and nonimmune drug hypersensitivity reactions have been estimated to comprise 25% of all adverse drug events.

article thumbnail

Solve Common Pharmacy Deficiencies with NABP’s Accreditation Solutions

National Association of Boards of Pharmacy

We have found that some pharmacies’ patient profiles contain incomplete information, with critical elements missing. If a pharmacy is not collecting all required patient information, any drug utilization review (DUR) performed by the pharmacist will be incomplete.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Medication Counselling

RX Note

The drug-related content is significantly expanded, with detailed information on special populations (pregnancy, breastfeeding, elderly, and paediatric) as well as side effects and their management. Nevertheless, counseling checklists represent the bare minimum of required information. what is the importance of sugar control).

article thumbnail

How AI Brings Pharmacogenetics to the Frontline of Precision Medicine

Pharmacy Times

This change mirrored a January 2025 FDA safety alert and label update that urged providers to consider genetic testing, inform patients of the risks, and discuss available options. Pharmacists’ involvement in these areas is crucial, from patient education and dose adjustment to monitoring outcomes. Accessed July 21, 2025. link] Roses AD.

article thumbnail

FDA Issues Complete Response Letter to Manufacturer of OLC, Treatment for CKD-Related Hyperphosphatemia

Pharmacy Times

Common adverse reactions included gastrointestinal issues, with a low discontinuation rate due to adverse drug reactions. 2024zjjtxrrv Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. 2024;35(10S). doi:10.1681/ASN.2024zjjtxrrv

article thumbnail

Mitomycin Intravesical Solution Receives FDA Approval for Non-Muscle Invasive Bladder Cancer

Pharmacy Times

3 The safety profile was favorable with the most common adverse effect (AE) being increased creatinine, increased potassium, dysuria, decreased hemoglobin, increased aspartate aminotransferase, increased alanine aminotransferase, increased eosinophils, decreased lymphocytes, urinary tract infection, decreased neutrophils, and hematuria.

article thumbnail

Donanemab-Azbt Receives FDA Label Update With New Dosing for Alzheimer Disease

Pharmacy Times

While no new adverse reactions were observed in this study, higher rates of hypersensitivity and infusion-related reactions were observed. link] Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Accessed July 9, 2025.